TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32691164

Group type: COMPARATOR
Intervention: Lisdexamfetamine dimesylate (LDX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Guanfacine extended release (GXR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline WFIRS‐P scores
Number of subjects: 0
Study: 35363780

Group type: EXPERIMENTAL
Intervention: Intervention (source reduction intervention)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Control
Number of subjects: 520
Study: 33735465

Group type: EXPERIMENTAL
Intervention: BFRRE to failure (Failure)
Number of subjects: 17

Group type: COMPARATOR
Intervention: BFRRE not to failure (Non-failure)
Number of subjects: 17
Study: 32897014

Group type: EXPERIMENTAL
Intervention: Phenazopyridine 200 mg administered 20 minutes before cystoscopy and then 200 mg every 8 hours (total three doses) with lidocaine gel
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Phenazopyridine with lidocaine gel
Number of subjects: 97

Group type: COMPARATOR
Intervention: Lidocaine gel
Number of subjects: 97
Study: 33428636

Group type: EXPERIMENTAL
Intervention: Intervention villages
Number of subjects: 394

Group type: COMPARATOR
Intervention: Control villages
Number of subjects: 394
Study: 33027827

Group type: EXPERIMENTAL
Intervention: General practitioners' home visits
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Age of the doctor
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Regional characteristics
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Multivariate regression analysis
Number of subjects: 303
Study: 34127014

Group type: EXPERIMENTAL
Intervention: BA (5.0 g·day‐1 of β‐alanine)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: ALK (0.07 g·kgFFM‐1·day‐1 of sodium bicarbonate)
Number of subjects: 9

Group type: COMPARATOR
Intervention: BA combined with BCAA and TCM
Number of subjects: 9

Group type: COMPARATOR
Intervention: ALK combined with BCAA and TCM
Number of subjects: 9
Study: 36322882

Group type: EXPERIMENTAL
Intervention: Smartphone problem-solving therapy and behavioral activation apps
Number of subjects: 447

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 447
Study: 33769540

Group type: EXPERIMENTAL
Intervention: 313‐variant Polygenic Risk Score (PRS313)
Number of subjects: 18434

Group type: EXPERIMENTAL
Intervention: Recalibrated Polygenic Risk Score
Number of subjects: 18434
Study: 32552366

Group type: EXPERIMENTAL
Intervention: Intervention to address IPV in pregnant women
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Integration of mental health services into primary ANC services
Number of subjects: 16
Study: 35124433

Group type: EXPERIMENTAL
Intervention: Cognitive remediation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vocational services alone
Number of subjects: 0
Study: 33217221

Group type: EXPERIMENTAL
Intervention: Robotic kidney transplant
Number of subjects: 25

Group type: COMPARATOR
Intervention: Open kidney transplant
Number of subjects: 25
Study: 32223587

Group type: EXPERIMENTAL
Intervention: Intrauterine surgery (Group I)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Postnatal surgery (Group II)
Number of subjects: 87
Study: 33244655

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid management
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional fluid treatment
Number of subjects: 60
Study: 35290152

Group type: EXPERIMENTAL
Intervention: TV003
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: TV005
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 34936739

Group type: EXPERIMENTAL
Intervention: Spesolimab (900 mg intravenous dose)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 34583344

Group type: EXPERIMENTAL
Intervention: Azithromycin (single oral dose)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Amoxicillin (7-day course)
Number of subjects: 301
Study: 33941639

Group type: EXPERIMENTAL
Intervention: s-MoCA-SWE
Number of subjects: 0
Study: 32606341

Group type: EXPERIMENTAL
Intervention: Statistical mechanical approach for ensembles of time series designed to preserve statistical properties of empirical time series; specific dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unsupervised, data‐driven framework for hypothesis testing; specific dosage and duration not available.
Number of subjects: 0
Study: 34881675

Group type: EXPERIMENTAL
Intervention: School-based intervention
Number of subjects: 374

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 374
Study: 32521100

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 225
Study: 33610228

Group type: EXPERIMENTAL
Intervention: BI 425809 10 mg
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: BI 425809 25 mg
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: BI 425809 2 mg
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: BI 425809 5 mg
Number of subjects: 509

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509
Study: 33750085

Group type: EXPERIMENTAL
Intervention: Telerehabilitation (8 weeks, 5 days/week, daily cost of 74 PLN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (costs from extra in-patient and out-patient rehabilitation)
Number of subjects: 0
Study: 32174354

Group type: EXPERIMENTAL
Intervention: Virtual reality headsets
Number of subjects: 27
Study: 35273051

Group type: EXPERIMENTAL
Intervention: Mobile Integrated Health (MIH) intervention which includes home visits from a community paramedic and telehealth video visits by emergency medicine physicians.
Number of subjects: 2100

Group type: COMPARATOR
Intervention: Transitions of Care Coordinators (TOCC) intervention which consists of follow-up phone calls from a registered nurse within 48-72 hours of discharge.
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: Mobile Integrated Health (MIH) intervention
Number of subjects: 2100

Group type: COMPARATOR
Intervention: Transitions of Care Coordinators (TOCC) intervention
Number of subjects: 2100
Study: 33136119

Group type: EXPERIMENTAL
Intervention: INT (theory-based lifestyle intervention)
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: INT-DPM (lifestyle intervention with diabetes prevention mentors)
Number of subjects: 1028

Group type: COMPARATOR
Intervention: CON (usual care)
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: Combined interventions (INT and INT-DPM)
Number of subjects: 1028
Study: 33095184

Group type: EXPERIMENTAL
Intervention: SCAMPI program (intervention group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Static WeChat page for standard smoking cessation care (control group)
Number of subjects: 80
Study: 35706495

Group type: EXPERIMENTAL
Intervention: 16-weeks aerobic exercise training (three sessions per week of 60 min at 60–80% peak heart rate, physical activity self-monitoring, motivational coaching)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: 16-weeks aerobic exercise training
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control group (educational materials on hypertension and recommended lifestyle behaviours)
Number of subjects: 203
Study: 32007641

Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study: 33463428

Group type: EXPERIMENTAL
Intervention: Combined ACL reconstruction and ALL suture tape augmentation (Group 2, n=30)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Isolated ACL reconstruction (Group 1, n=33)
Number of subjects: 63
Study: 32736542

Group type: EXPERIMENTAL
Intervention: Aerobic exercise during chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group (usual care during chemotherapy and aerobic exercise post-chemotherapy)
Number of subjects: 0
Study: 36150312

Group type: EXPERIMENTAL
Intervention: Yoga group
Number of subjects: 140

Group type: COMPARATOR
Intervention: Routine hospital care (control group)
Number of subjects: 140
Study: 36263860

Group type: EXPERIMENTAL
Intervention: Nasopharyngeal tube (NPT) insertion
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no NPT insertion)
Number of subjects: 45
Study: 33557019

Group type: EXPERIMENTAL
Intervention: Fluids of different osmolarity and minerals contents
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fluids of different osmolarity
Number of subjects: 14

Group type: COMPARATOR
Intervention: Mineralized water
Number of subjects: 14
Study: 34842950

Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617 (6.0-7.4 GBq/cycle, every 8 weeks, up to 4 cycles)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2/cycle, every 3 weeks, up to 10 cycles)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617
Number of subjects: 40

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 40
Study: 34351460

Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cell therapy (180,000 ± 35,000 cells injected)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Core decompression without cells (control group)
Number of subjects: 50
Study: 34242551

Group type: EXPERIMENTAL
Intervention: Negative affect induction
Number of subjects: 150

Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Emotion suppression
Number of subjects: 150
Study: 34423625

Group type: EXPERIMENTAL
Intervention: Lever positioning manipulation combined with pulsed electric field
Number of subjects: 58

Group type: COMPARATOR
Intervention: Pulsed electric field (Control)
Number of subjects: 58
Study: 615920838

Group type: EXPERIMENTAL
Intervention: Spectral domain optical coherence tomography (SD-OCT)
Number of subjects: 20
Study: 35213666

Group type: COMPARATOR
Intervention: Good olfaction (B-SIT score 10-11)
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: Anosmia (score≤6)
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: Hyposmia (7-8)
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: Olfactory function
Number of subjects: 2531
Study: 33968362

Group type: EXPERIMENTAL
Intervention: Sending a pre-notification card
Number of subjects: 558

Group type: COMPARATOR
Intervention: Not sending a pre-notification card
Number of subjects: 558
Study: 32406746

Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT) for 12 weeks, n = 12
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT) for 16 weeks, n = 10
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT) for 20 weeks, n = 8
Number of subjects: 30
Study: 33576411

Group type: EXPERIMENTAL
Intervention: SPT from a chair (35 cm seat height)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SDL using hex-bar
Number of subjects: 32
Study: 33544759

Group type: EXPERIMENTAL
Intervention: Maternal TDF-ART (Tenofovir disoproxil fumarate / Emtricitabine + Lopinavir/ritonavir)
Number of subjects: 398

Group type: COMPARATOR
Intervention: Infant nevirapine prophylaxis (no maternal antiretroviral therapy)
Number of subjects: 398
Study: 32124574

Group type: EXPERIMENTAL
Intervention: Milieu Therapy and routine hospital treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine treatment in the hospital
Number of subjects: 100
Study: 35774395

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (200,000 IU intramuscular cholecalciferol)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oral vancomycin (control)
Number of subjects: 18
Study: 32887851

Group type: COMPARATOR
Intervention: Low load resistance training (LOW, n = 15)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Moderate load resistance training (MOD, n = 14)
Number of subjects: 29
Study: 35319844

Group type: EXPERIMENTAL
Intervention: He's santong acupuncture therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 60
Study: 32996450

Group type: EXPERIMENTAL
Intervention: Private toilet access
Number of subjects: 2044

Group type: EXPERIMENTAL
Intervention: Public toilet access
Number of subjects: 2044

Group type: COMPARATOR
Intervention: No toilet access
Number of subjects: 2044

Group type: EXPERIMENTAL
Intervention: Overall defecation behavior
Number of subjects: 2044
Study: 34276021

Group type: EXPERIMENTAL
Intervention: BigThumb Group (BT Group)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Traditional Follow-up Group (TF Group)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: AI algorithm
Number of subjects: 218
Study: 33124506

Group type: EXPERIMENTAL
Intervention: Intensified Oral Hygiene Care (IOHC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine Oral Hygiene Care (Control)
Number of subjects: 0
Study: 37948286

Group type: EXPERIMENTAL
Intervention: Precision nutrition counseling (six weekly sessions)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (educational pamphlets)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Overall subjects (both groups)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: eHealth application
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Precision nutrition counseling
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: DNA-based nutrition counseling
Number of subjects: 138
Study: 33064852

Group type: EXPERIMENTAL
Intervention: Rectal misoprostol (preoperative)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Intrauterine misoprostol (intraoperative)
Number of subjects: 98
Study: 32406112

Group type: EXPERIMENTAL
Intervention: linaclotide (290 µg)
Number of subjects: 39

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 39
Study: 36029502

Group type: EXPERIMENTAL
Intervention: CLCG group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Mild CLCG group
Number of subjects: 200
Study: 32145794

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus cetuximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiotherapy plus cisplatin
Number of subjects: 0
Study: 33909985

Group type: EXPERIMENTAL
Intervention: RemindMe (interactive digital calendar with mobile phone reminders)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Usual treatment by an occupational therapist
Number of subjects: 15
Study: 33008264

Group type: EXPERIMENTAL
Intervention: CRVO patients
Number of subjects: 95
Study: 34215235

Group type: EXPERIMENTAL
Intervention: Housing First (HF)
Number of subjects: 703

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 703
Study: 32441183

Group type: EXPERIMENTAL
Intervention: Attitudes, self-efficacy, habits, and intention
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Women who did not want to quit hookah
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Knowledge and Social norms
Number of subjects: 332
Study: 34995417

Group type: EXPERIMENTAL
Intervention: GSK3640254 tablet formulation 200 mg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: GSK3640254 tablet formulation 200 mg under high-fat conditions
Number of subjects: 39
Study: 34291981

Group type: EXPERIMENTAL
Intervention: Black Atheist
Number of subjects: 343

Group type: COMPARATOR
Intervention: Black Christian
Number of subjects: 343

Group type: COMPARATOR
Intervention: Unknown religious affiliation
Number of subjects: 343
Study: 33155849

Group type: EXPERIMENTAL
Intervention: Diclofenac emulgel
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Ibuprofen gel
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Ketoprofen gel
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Diclofenac (any formulation)
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 15000
Study: 35742721

Group type: EXPERIMENTAL
Intervention: Interaction and cognitive engagement-based blended teaching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual teaching
Number of subjects: 0
Study: 32940336

Group type: EXPERIMENTAL
Intervention: Anti-H pylori treatment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 32762637

Group type: EXPERIMENTAL
Intervention: Patient navigation program (letter followed by a phone call from navigators)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Patient navigation program (among 56 intervention patients who received navigation)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Patient navigation program (in subgroup of patients with SUD)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 251
Study: 34342035

Group type: EXPERIMENTAL
Intervention: Carfilzomib before daratumumab (Car‐Da)
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Daratumumab after carfilzomib (Da‐Car)
Number of subjects: 635

Group type: COMPARATOR
Intervention: Daratumumab (used before or after carfilzomib)
Number of subjects: 635
Study: 33161736

Group type: EXPERIMENTAL
Intervention: Probiotic (Bacillus subtilis DE111)
Number of subjects: 100
Study: 35859408

Group type: EXPERIMENTAL
Intervention: One shade universal composite, Omnichroma
Number of subjects: 25
Study: 34687253

Group type: EXPERIMENTAL
Intervention: LL-37 at 0.5 mg/mL
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: LL-37 at 1.6 mg/mL
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: LL-37 (both concentrations) in subgroup with large target wounds (≥10 cm2)
Number of subjects: 148
Study: 35172856

Group type: EXPERIMENTAL
Intervention: Guideline implementation (active implementation of an evidence-based feeding guideline)
Number of subjects: 2772

Group type: COMPARATOR
Intervention: Control group (no awareness of guideline content)
Number of subjects: 2772
Study: 34428542

Group type: EXPERIMENTAL
Intervention: PEG IFN-α2b + SOC
Number of subjects: 250

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 250
Study: 33530828

Group type: EXPERIMENTAL
Intervention: Notched peripheral intravenous catheter
Number of subjects: 658

Group type: COMPARATOR
Intervention: Traditional non-notched catheter
Number of subjects: 658
Study: 34479071

Group type: EXPERIMENTAL
Intervention: Municipality-based intervention (n=1,545)
Number of subjects: 3103

Group type: COMPARATOR
Intervention: Hospital-based intervention (n=1,558)
Number of subjects: 3103

Group type: EXPERIMENTAL
Intervention: Municipality-based intervention
Number of subjects: 3103

Group type: COMPARATOR
Intervention: Hospital-based intervention
Number of subjects: 3103
Study: 35778714

Group type: EXPERIMENTAL
Intervention: Methotrexate plus placebo
Number of subjects: 775
Study: 34366941

Group type: EXPERIMENTAL
Intervention: Informative pop-up messages
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Self-appraisal pop-ups
Number of subjects: 58

Group type: COMPARATOR
Intervention: Blank pop-up messages
Number of subjects: 58
Study: 32473033

Group type: EXPERIMENTAL
Intervention: Active ingredients from Angelicae Pubescentis Radix (AP) identified through spectrum–effect relationship method.
Number of subjects: 0
Study: 35575427

Group type: EXPERIMENTAL
Intervention: Positive Parenting Program to Promote Child Development (experimental group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 60
Study: 34848294

Group type: EXPERIMENTAL
Intervention: Pharmacist-facilitated antibiotic timeout
Number of subjects: 288

Group type: COMPARATOR
Intervention: Control services
Number of subjects: 288
Study: 33541535

Group type: EXPERIMENTAL
Intervention: IVUS-guided group
Number of subjects: 1448

Group type: COMPARATOR
Intervention: Angiography-guided group
Number of subjects: 1448
Study: 616118509

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB; 1.5 mg/0.06 cc)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR; 0.5 mg/0.06 cc)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Focal DME
Number of subjects: 45
Study: 34452594

Group type: EXPERIMENTAL
Intervention: Nationwide epidemiologic survey of USH
Number of subjects: 1628

Group type: EXPERIMENTAL
Intervention: Genetic testing and counseling for USH patients
Number of subjects: 1628
Study: 33896402

Group type: EXPERIMENTAL
Intervention: Couples Coping Enhancement Training (CCET)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 33206794

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) 150mg, two tablets daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 36419987

Group type: EXPERIMENTAL
Intervention: Delta Medical's PEEK interference screw and EndoButton
Number of subjects: 104

Group type: COMPARATOR
Intervention: Smith & Nephew's PEEK interference screw and EndoButton
Number of subjects: 104
Study: 33080486

Group type: EXPERIMENTAL
Intervention: Single-dose metronidazole (MTZ)
Number of subjects: 1477

Group type: COMPARATOR
Intervention: Multidose metronidazole (MTZ)
Number of subjects: 1477
Study: 33971288

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous intensity cycling (60 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (resting)
Number of subjects: 30
Study: 33749456

Group type: EXPERIMENTAL
Intervention: Prevalence statistics in percentage formats
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-message control group
Number of subjects: 0
Study: 33934474

Group type: EXPERIMENTAL
Intervention: Gel cream containing piroctone olamine, biosaccharide gum-2, stearyl glycyrrhetinate, and zinc l-pyrrolidone carboxylate, applied twice daily for 30 days
Number of subjects: 10
Study: 36448321

Group type: EXPERIMENTAL
Intervention: Microemulsion gel formula (288 mg α-tocopherol)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dry solid tablet (288 mg α-tocopherol)
Number of subjects: 12
Study: 32121288

Group type: EXPERIMENTAL
Intervention: Health center staff training and home visits by community health volunteers
Number of subjects: 2494
Study: 36041751

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 34398311

Group type: EXPERIMENTAL
Intervention: Peloidotherapy (heated mudpack at 41-42°C on painful and active joints, 5 days/week for 2 weeks)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Peloidotherapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 56
Study: 35093068

Group type: EXPERIMENTAL
Intervention: Prognostic model based on 19 prognostic ferroptosis-related long noncoding RNAs (FRLs)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: High-risk group based on risk score from the prognostic model
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Risk score from the prognostic model
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Stage of LUAD
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Expression of 34 checkpoint genes and 13 m6A-related genes
Number of subjects: 504